Galluzzi P, Filosomi G, Vallone IM, Bardelli AM, Venturi C

MRI of Wolfram syndrome (DIDMOAD).

Neuroradiology 1999; 729-31. doi: 10.1007/s002340050832

Giordano S, Maffe A, Williams TA, Artigiani S, Gual P, Bardelli A, Basilico C, Michieli P, Comoglio PM

Different point mutations in the met oncogene elicit distinct biological properties.

FASEB J 2000; 399-406. doi: 10.1096/fasebj.14.2.399

Bardelli A, Cahill DP, Lederer G, Speicher MR, Kinzler KW, Vogelstein B, Lengauer C

Carcinogen-specific induction of genetic instability.

Proc Natl Acad Sci U S A 2001; 5770-5. doi: 10.1073/pnas.081082898

Meloni I, Rubegni P, De Aloe G, Bruttini M, Pianigiani E, Cusano R, Seri M, Mondillo S, Federico A, Bardelli AM, Andreassi L, Fimiani M, Renieri A

Pseudoxanthoma elasticum: Point mutations in the ABCC6 gene and a large deletion including also ABCC1 and MYH11.

Hum Mutat 2001; 85. doi: 10.1002/humu.1157

Malandrini A, Mari F, Palmeri S, Gambelli S, Berti G, Bruttini M, Bardelli AM, Williamson K, van Heyningen V, Renieri A

PAX6 mutation in a family with aniridia, congenital ptosis, and mental retardation.

Clin Genet 2001; 151-4. doi: 10.1034/j.1399-0004.2001.600210.x

Galluzzi P, Venturi C, Cerase A, Vallone IM, Bracco S, Bardelli AM, Hadjistilianou T, Gennari P, Monti L, Filosomi G

Coats disease: smaller volume of the affected globe.

Radiology 2001; 64-9. doi: 10.1148/radiol.2211010017

Saha S, Bardelli A, Buckhaults P, Velculescu VE, Rago C, St Croix B, Romans KE, Choti MA, Lengauer C, Kinzler KW, Vogelstein B

A phosphatase associated with metastasis of colorectal cancer.

Science 2001; 1343-6. doi: 10.1126/science.1065817

Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE

Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.

Nature 2002; 934. doi: 10.1038/418934a

Bardelli A, Parsons DW, Silliman N, Ptak J, Szabo S, Saha S, Markowitz S, Willson JK, Parmigiani G, Kinzler KW, Vogelstein B, Velculescu VE

Mutational analysis of the tyrosine kinome in colorectal cancers.

Science 2003; 949. doi: 10.1126/science.1082596

Buckhaults P, Zhang Z, Chen YC, Wang TL, St Croix B, Saha S, Bardelli A, Morin PJ, Polyak K, Hruban RH, Velculescu VE, Shih IeM

Identifying tumor origin using a gene expression-based classification map.

Cancer Res 2003; 4144-9.

Bardelli A, Saha S, Sager JA, Romans KE, Xin B, Markowitz SD, Lengauer C, Velculescu VE, Kinzler KW, Vogelstein B

PRL-3 expression in metastatic cancers.

Clin Cancer Res 2003; 5607-15.

Bachman KE, Blair BG, Brenner K, Bardelli A, Arena S, Zhou S, Hicks J, De Marzo AM, Argani P, Park BH

p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells.

Cancer Biol Ther 2004; 221-5. doi: 10.4161/cbt.3.2.666

Wang TL, Diaz LA, Romans K, Bardelli A, Saha S, Galizia G, Choti M, Donehower R, Parmigiani G, Shih IeM, Iacobuzio-Donahue C, Kinzler KW, Vogelstein B, Lengauer C, Velculescu VE

Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients.

Proc Natl Acad Sci U S A 2004; 3089-94. doi: 10.1073/pnas.0308716101

Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE

High frequency of mutations of the PIK3CA gene in human cancers.

Science 2004; 554. doi: 10.1126/science.1096502

Wang Z, Shen D, Parsons DW, Bardelli A, Sager J, Szabo S, Ptak J, Silliman N, Peters BA, van der Heijden MS, Parmigiani G, Yan H, Wang TL, Riggins G, Powell SM, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE

Mutational analysis of the tyrosine phosphatome in colorectal cancers.

Science 2004; 1164-6. doi: 10.1126/science.1096096

Parker BS, Argani P, Cook BP, Liangfeng H, Chartrand SD, Zhang M, Saha S, Bardelli A, Jiang Y, St Martin TB, Nacht M, Teicher BA, Klinger KW, Sukumar S, Madden SL

Alterations in vascular gene expression in invasive breast carcinoma.

Cancer Res 2004; 7857-66. doi: 10.1158/0008-5472.CAN-04-1976

Kohli M, Yu J, Seaman C, Bardelli A, Kinzler KW, Vogelstein B, Lengauer C, Zhang L

SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells.

Proc Natl Acad Sci U S A 2004; 16897-902. doi: 10.1073/pnas.0403405101

Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG

Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.

Cancer Res 2004; 8816-20. doi: 10.1158/0008-5472.CAN-04-1923

Bachman KE, Sager J, Cheong I, Catto M, Bardelli A, Park BH, Vogelstein B, Carotti A, Kinzler KW, Lengauer C

Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine-resistant cancer cells.

Mol Cancer Ther 2005; 1026-30. doi: 10.1158/1535-7163.MCT-05-0038

Parsons DW, Wang TL, Samuels Y, Bardelli A, Cummins JM, DeLong L, Silliman N, Ptak J, Szabo S, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Lengauer C, Velculescu VE

Colorectal cancer: mutations in a signalling pathway.

Nature 2005; 792. doi: 10.1038/436792a

Polato F, Codegoni A, Fruscio R, Perego P, Mangioni C, Saha S, Bardelli A, Broggini M

PRL-3 phosphatase is implicated in ovarian cancer growth.

Clin Cancer Res 2005; 6835-9. doi: 10.1158/1078-0432.CCR-04-2357

Balakrishnan A, Bleeker FE, Lamba S, Rodolfo M, Daniotti M, Scarpa A, van Tilborg AA, Leenstra S, Zanon C, Bardelli A

Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma.

Cancer Res 2007; 3545-50. doi: 10.1158/0008-5472.CAN-07-0065

Benvenuti S, Frattini M, Arena S, Zanon C, Cappelletti V, Coradini D, Daidone MG, Pilotti S, Pierotti MA, Bardelli A

PIK3CA cancer mutations display gender and tissue specificity patterns.

Hum Mutat 2008; 284-8. doi: 10.1002/humu.20648

Liedtke C, Cardone L, Tordai A, Yan K, Gomez HL, Figureoa LJ, Hubbard RE, Valero V, Souchon EA, Symmans WF, Hortobagyi GN, Bardelli A, Pusztai L

PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer.

Breast Cancer Res 2008; R27. doi: 10.1186/bcr1984

Bleeker FE, Felicioni L, Buttitta F, Lamba S, Cardone L, Rodolfo M, Scarpa A, Leenstra S, Frattini M, Barbareschi M, Grammastro MD, Sciarrotta MG, Zanon C, Marchetti A, Bardelli A

AKT1(E17K) in human solid tumours.

Oncogene 2008; 5648-50. doi: 10.1038/onc.2008.170

Di Nicolantonio F, Martini M, Molinari F, Sartore-Bianchi A, Arena S, Saletti P, De Dosso S, Mazzucchelli L, Frattini M, Siena S, Bardelli A

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.

J Clin Oncol 2008; 5705-12. doi: 10.1200/JCO.2008.18.0786

Di Nicolantonio F, Arena S, Gallicchio M, Zecchin D, Martini M, Flonta SE, Stella GM, Lamba S, Cancelliere C, Russo M, Geuna M, Appendino G, Fantozzi R, Medico E, Bardelli A

Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses.

Proc Natl Acad Sci U S A 2008; 20864-9. doi: 10.1073/pnas.0808757105

Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP, Frattini M, Molinari F, Knowles M, Cerrato A, Rodolfo M, Scarpa A, Felicioni L, Buttitta F, Malatesta S, Marchetti A, Bardelli A

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors.

Hum Mutat 2009; 7-11. doi: 10.1002/humu.20937

Sartore-Bianchi A, Martini M, Molinari F, Veronese S, Nichelatti M, Artale S, Di Nicolantonio F, Saletti P, De Dosso S, Mazzucchelli L, Frattini M, Siena S, Bardelli A

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.

Cancer Res 2009; 1851-7. doi: 10.1158/0008-5472.CAN-08-2466

Bleeker FE, Lamba S, Zanon C, van Tilborg AA, Leenstra S, Troost D, Hulsebos T, Vandertop WP, Bardelli A

Absence of AKT1 mutations in glioblastoma.

PLoS One 2009; e5638. doi: 10.1371/journal.pone.0005638

Balakrishnan A, Penachioni JY, Lamba S, Bleeker FE, Zanon C, Rodolfo M, Vallacchi V, Scarpa A, Felicioni L, Buck M, Marchetti A, Comoglio PM, Bardelli A, Tamagnone L

Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.

Hum Mutat 2009; 1167-74. doi: 10.1002/humu.21017

Palmioli A, Sacco E, Airoldi C, Di Nicolantonio F, D'Urzo A, Shirasawa S, Sasazuki T, Di Domizio A, De Gioia L, Martegani E, Bardelli A, Peri F, Vanoni M

Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-Ras(G13D).

Biochem Biophys Res Commun 2009; 593-7. doi: 10.1016/j.bbrc.2009.06.069

%PLACEHOLDER%